Skip to Main Content

Paper Details

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.
Nat Commun
20
2022
INHBE, activin family, adipose tissue, cardiometabolic disease, causal genes, circulating growth factor, diabetes, hepatocytes, inhibin, lipodystrophies, metabolic disease, rare coding variants, type 2 diabetes
Author NameAffiliation
George HindyRegeneron Pharmaceuticals Inc
Giusy Della GattaRegeneron Pharmaceuticals Inc
Christopher D StillGeisinger Obesity Institute
David J CareyLund University
David J CareyUniversity of Verona
David J CareyLund University
David J CareyUniversity of Verona
Marju Orho-MelanderUnidad de Medicina Experimental de la Facultad de Medicina de la Universidad Nacional Autonoma de Mexico
Rory CollinsPerelman School of Medicine, University of Pennsylvania
Daniel J RaderRegeneron Pharmaceuticals Inc
Andrew J MurphyRegeneron Pharmaceuticals Inc
John D OvertonRegeneron Pharmaceuticals Inc
John D OvertonRegeneron Pharmaceuticals Inc
Jeffrey G ReidRegeneron Pharmaceuticals Inc
Jeffrey G ReidRegeneron Pharmaceuticals Inc
Alan R ShuldinerRegeneron Pharmaceuticals Inc
Alan R ShuldinerRegeneron Pharmaceuticals Inc
Gon??alo R AbecasisRegeneron Pharmaceuticals Inc
Gon??alo R AbecasisRegeneron Pharmaceuticals Inc
Viktoria GusarovaRegeneron Pharmaceuticals Inc
Tooraj MirshahiGeisinger Obesity Institute
George D YancopoulosRegeneron Pharmaceuticals Inc
Olle MelanderLund University
Olle MelanderSkane University Hospital
Jonathan MarchiniRegeneron Pharmaceuticals Inc
Jonathan MarchiniRegeneron Pharmaceuticals Inc
Adam E LockeRegeneron Pharmaceuticals Inc
Aris BarasRegeneron Pharmaceuticals Inc
Niek VerweijRegeneron Pharmaceuticals Inc
Luca A LottaRegeneron Pharmaceuticals Inc
  • 1 - 30

Datasets

Release 1.2